How much funding has Spirox raised?

Spirox has raised $63.5M in total funding, most recently a series c round.

Who are Spirox's investors?

Spirox's investors include Aisling Capital, Venrock, Entellus Medical, KKR, Aperture Venture Capital, HealthQuest Capital.

Where is Spirox headquartered?

Spirox is headquartered in Menlo Park, California, United States.

Spirox

Acquired

Menlo Park, United States · Founded 2013 · $63.5M raised

Healthcare

Headquarters: Menlo Park, California
Employees: 11–50
Founded: 2013
Business Model: B2B

Website: spiroxmedical.com
Total Funding: $63.5M
Last Round: $45.0M Series CMar 2016
Rounds: 2

About

Spirox Medical was a Menlo Park, California-based medical device company that developed the LATERA absorbable nasal implant, a minimally invasive device for treating nasal airway obstruction and improving nasal breathing. The LATERA implant received FDA clearance in 2016. Stryker acquired Spirox Medical in 2017 to expand its ENT portfolio.

Summary

Spirox is a Healthcare company based in Menlo Park, United States, founded in 2013. It has raised $63.5M in total across 2 rounds, most recently a $45.0M Series C round in Mar 2016. Investors include Aisling Capital, Venrock and Entellus Medical.